Insmed Inc. buy UBS Group AG
Start price
27.02.24
/
50%
€26.80
Target price
27.02.25
€42.39
Performance (%)
181.72%
End price
28.02.25
€75.50
Summary
This prediction ended on 28.02.25 with a price of €75.50. The BUY prediction by UBS_Group_AG for Insmed Inc. saw massive gains of 181.72%. UBS_Group_AG has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 1.471% | 1.471% | -0.838% |
| iShares Core DAX® | 0,27 % | 2,50 % | 3,33 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % | 35,66 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % | 56,65 % |
| iShares S&P 500 | 0,15 % | 1,92 % | 24,11 % |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten